GR3023708T3 - N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists - Google Patents
N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonistsInfo
- Publication number
- GR3023708T3 GR3023708T3 GR970401349T GR970401349T GR3023708T3 GR 3023708 T3 GR3023708 T3 GR 3023708T3 GR 970401349 T GR970401349 T GR 970401349T GR 970401349 T GR970401349 T GR 970401349T GR 3023708 T3 GR3023708 T3 GR 3023708T3
- Authority
- GR
- Greece
- Prior art keywords
- alkyl
- variables
- alkoxy
- hydrogen
- alkoxycarbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH240591 | 1991-08-15 | ||
CH37592 | 1992-02-07 | ||
CH114192 | 1992-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3023708T3 true GR3023708T3 (en) | 1997-09-30 |
Family
ID=27172057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR970401349T GR3023708T3 (en) | 1991-08-15 | 1997-06-09 | N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists |
Country Status (16)
Country | Link |
---|---|
US (3) | US5955487A (el) |
EP (1) | EP0528762B1 (el) |
JP (1) | JPH05230022A (el) |
KR (1) | KR930004295A (el) |
AT (1) | ATE152718T1 (el) |
AU (1) | AU659469B2 (el) |
CA (1) | CA2076057A1 (el) |
DE (1) | DE59208448D1 (el) |
DK (1) | DK0528762T3 (el) |
ES (1) | ES2101824T3 (el) |
FI (1) | FI923612A (el) |
GR (1) | GR3023708T3 (el) |
HU (1) | HUT62880A (el) |
IL (1) | IL102802A0 (el) |
MX (1) | MX9204703A (el) |
NO (1) | NO923182L (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2683819B1 (fr) * | 1991-10-28 | 1994-02-11 | Synthelabo | Derives de quinoleine, leur procede de preparation et leur application en therapeutique. |
GB9208116D0 (en) | 1992-04-13 | 1992-05-27 | Ici Plc | Therapeutic agents |
ES2135472T3 (es) * | 1992-04-13 | 1999-11-01 | Zeneca Ltd | Antagonistas de angiotensina ii contra trastornos asociados con la velocidad de conduccion neuronal deteriorada, especialmente la neuropatia diabetica. |
US5478832A (en) * | 1992-05-08 | 1995-12-26 | The Green Cross Corporation | Quinoline compounds |
GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
FR2710914B1 (fr) * | 1993-10-04 | 1995-11-24 | Synthelabo | Dérivés de 2-[2-(tétrazol-5-yl)phényl]-1,2-dihydroquinoléine, leur préparation et leur utilisation comme intermédiaires de synthèse. |
JPH09202774A (ja) | 1996-01-25 | 1997-08-05 | Green Cross Corp:The | 2−アリールキノリン類およびその製造方法 |
US5919792A (en) * | 1996-10-30 | 1999-07-06 | Merck & Co., Inc. | Integrin antagonists |
JP3892963B2 (ja) * | 1998-03-17 | 2007-03-14 | 住友化学株式会社 | L−バリンベンジルエステルp−トルエンスルホン酸塩の製造方法 |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US7417065B2 (en) * | 2003-05-19 | 2008-08-26 | Irm Llc | Immunosuppressant compounds and compositions |
MY150088A (en) * | 2003-05-19 | 2013-11-29 | Irm Llc | Immunosuppressant compounds and compositions |
WO2005009993A1 (en) * | 2003-07-15 | 2005-02-03 | Smithkline Beecham Corporation | Novel compounds |
US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
CN101022802A (zh) | 2004-07-22 | 2007-08-22 | Ptc医疗公司 | 用于治疗丙型肝炎的噻吩并吡啶化合物 |
DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
CN102711468B (zh) * | 2009-09-23 | 2014-07-09 | 梅迪维新技术公司 | 吡啶并[4,3-b]吲哚化合物及其使用方法 |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2417763A1 (de) * | 1974-04-11 | 1975-10-30 | Bayer Ag | Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
EP0411507B1 (en) * | 1989-08-02 | 1994-10-26 | Takeda Chemical Industries, Ltd. | Pyrazole derivatives, their production and use |
GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
GB8924755D0 (en) * | 1989-11-02 | 1989-12-20 | Bayer Ag | Iso-and heterocyclic phenylsulphonylamides |
PT95899A (pt) * | 1989-11-17 | 1991-09-13 | Glaxo Group Ltd | Processo para a preparacao de derivados indole |
GB8927277D0 (en) * | 1989-12-01 | 1990-01-31 | Glaxo Group Ltd | Chemical compounds |
CA2032259A1 (en) * | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Hiv protease inhibitors useful for the treatment of aids |
DE122007000050I1 (de) * | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
AU657498B2 (en) * | 1990-12-14 | 1995-03-16 | Novartis Ag | Biphenylyl compounds |
FR2689124A1 (fr) * | 1992-03-27 | 1993-10-01 | Adir | Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1992
- 1992-08-06 DE DE59208448T patent/DE59208448D1/de not_active Expired - Fee Related
- 1992-08-06 EP EP92810603A patent/EP0528762B1/de not_active Expired - Lifetime
- 1992-08-06 ES ES92810603T patent/ES2101824T3/es not_active Expired - Lifetime
- 1992-08-06 AT AT92810603T patent/ATE152718T1/de not_active IP Right Cessation
- 1992-08-06 DK DK92810603.8T patent/DK0528762T3/da not_active Application Discontinuation
- 1992-08-12 FI FI923612A patent/FI923612A/fi not_active Application Discontinuation
- 1992-08-12 AU AU20983/92A patent/AU659469B2/en not_active Ceased
- 1992-08-13 IL IL102802A patent/IL102802A0/xx unknown
- 1992-08-13 CA CA002076057A patent/CA2076057A1/en not_active Abandoned
- 1992-08-13 KR KR1019920014556A patent/KR930004295A/ko not_active Application Discontinuation
- 1992-08-13 US US07/929,616 patent/US5955487A/en not_active Expired - Fee Related
- 1992-08-14 HU HU9202654A patent/HUT62880A/hu unknown
- 1992-08-14 NO NO92923182A patent/NO923182L/no unknown
- 1992-08-14 MX MX9204703A patent/MX9204703A/es unknown
- 1992-08-17 JP JP4217716A patent/JPH05230022A/ja active Pending
-
1993
- 1993-07-27 US US08/097,740 patent/US5506240A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/472,102 patent/US5620998A/en not_active Expired - Fee Related
-
1997
- 1997-06-09 GR GR970401349T patent/GR3023708T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX9204703A (es) | 1993-12-01 |
JPH05230022A (ja) | 1993-09-07 |
HU9202654D0 (en) | 1992-10-28 |
KR930004295A (ko) | 1993-03-22 |
NO923182L (no) | 1993-02-16 |
US5620998A (en) | 1997-04-15 |
DE59208448D1 (de) | 1997-06-12 |
NO923182D0 (no) | 1992-08-14 |
AU2098392A (en) | 1993-02-25 |
FI923612A0 (fi) | 1992-08-12 |
HUT62880A (en) | 1993-06-28 |
US5955487A (en) | 1999-09-21 |
AU659469B2 (en) | 1995-05-18 |
ES2101824T3 (es) | 1997-07-16 |
US5506240A (en) | 1996-04-09 |
CA2076057A1 (en) | 1993-02-16 |
EP0528762A1 (de) | 1993-02-24 |
DK0528762T3 (da) | 1997-08-25 |
ATE152718T1 (de) | 1997-05-15 |
FI923612A (fi) | 1993-02-16 |
IL102802A0 (en) | 1993-01-31 |
EP0528762B1 (de) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3023708T3 (en) | N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists | |
DE69232022D1 (de) | Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren | |
HK1006967A1 (en) | Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation | |
HUP0300188A2 (hu) | Karbonsavszármazékok, mint IP-antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
FI941987A (fi) | Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset | |
DK0889875T3 (da) | Cycloproylalkansyrederivater | |
NO305950B1 (no) | 1-amidinofenyl-pyrrolidoner, piperidinoner, azetinoner som plateaggregeringshemmere og farmasoeytiske preparater inneholdende forbindelsene | |
ATE144253T1 (de) | Methanoanthracene als dopaminantagonisten | |
NO923200D0 (no) | Piperidin-derivater | |
EP0351385A3 (en) | New amidino and guanidino derivatives | |
NO960632D0 (no) | Nye bis-naftalimider for behandling av kreft | |
FI960149A0 (fi) | Kumariinien ja karbostyriilien käyttö PLA2:n estäjinä, uusia kumariineja ja karbostyriilejä, menetelmä niiden valmistamiseksi ja lääkkeitä | |
FI963440A (fi) | Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset | |
GR3021303T3 (en) | Benzimidazoles, pharmaceutical compositions containing them and process for their preparation | |
SE9103022L (sv) | Nya 5h-bensodiazepinderivat, farmaceutiska kompositioner innehaallande desamma samt foerfarande foer framstaellning av dessa | |
ES8802508A1 (es) | Procedimiento para preparar derivados alquenicos. | |
NO932513L (no) | N-alkyl-kinuklidinium-salter |